|1.||Cheng, Sheue-Yann: 14 articles (04/2015 - 09/2003)|
|2.||Dralle, Henning: 13 articles (10/2015 - 07/2002)|
|3.||Xing, Mingzhao: 10 articles (10/2015 - 08/2005)|
|4.||Willingham, Mark C: 10 articles (04/2015 - 09/2003)|
|5.||Chao, Tzu-Chieh: 8 articles (05/2012 - 05/2002)|
|6.||Lin, Jen-Der: 8 articles (05/2012 - 05/2002)|
|7.||Kebebew, Electron: 7 articles (04/2015 - 05/2006)|
|8.||Eng, Charis: 7 articles (07/2014 - 05/2003)|
|9.||Hoang-Vu, Cuong: 7 articles (09/2012 - 07/2002)|
|10.||Gimm, Oliver: 7 articles (06/2012 - 07/2002)|
08/01/2013 - "In this study, we determined the incidence patterns for follicular thyroid cancer and compared trends between the follicular and papillary thyroid cancers in the United States. "
05/01/2012 - "The aims of this study are to assess the clinical characteristics of papillary and follicular thyroid cancer in young patients and evaluate the long-term therapeutic outcomes and prognostic factors for cancer mortality and recurrence. "
03/01/2009 - "Our previous studies demonstrated that pretreatment of follicular thyroid carcinoma cell lines FTC-133 and FTC-238 resulted in decreased in vitro proliferation rates and reduced tumor cell growth of xenotransplants. "
08/01/2007 - "This study determined cancer survival rates and follow-up status at different pTNM stages to stratify risk groups in follicular thyroid carcinoma. "
05/01/2003 - "This study provides insight into genes that may be important in the molecular pathogenesis of follicular thyroid tumors, as well candidates for preoperative diagnosis of follicular thyroid carcinoma."
|2.||Thyroid Neoplasms (Thyroid Cancer)
09/01/2000 - "Mortality rates from thyroid cancer have fallen significantly in recent decades, almost certainly as the result of earlier diagnosis and improved treatment of differentiated (papillary and follicular) thyroid cancer. "
10/01/2015 - "This study assessed alternate staging systems on the outcome of overall survival, and compared these with current National Thyroid Cancer Treatment Cooperative Study (NTCTCS) staging systems for papillary and follicular thyroid cancer. "
07/01/2002 - "To compare and contrast the clinical presentation and treatment outcome of patients with papillary and follicular thyroid carcinoma and to study the pattern of practice of treatment of differentiated thyroid carcinoma in Hong Kong. "
01/01/2015 - "Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma."
01/01/2015 - "Here we report two cases of follicular thyroid cancer with skull involvement, and describe the diagnostic and therapeutic approach to metastatic thyroid cancer. "
|3.||Neoplasm Metastasis (Metastasis)
05/01/2009 - "Detection of SLN metastasis was helpful in diagnosing follicular thyroid cancer and thus enabling one-stage surgery."
04/01/2004 - "Of the 70 patients of follicular thyroid carcinoma with lung metastases, 30 patients (42.9%) died at the end of the follow-up, and only 4 patients improved to disease free status. "
01/01/2012 - "We review recent advances in the modeling of follicular thyroid carcinoma with distant metastasis and in the use of these mouse models in preclinical studies, emphasizing the significance of genetically engineered mouse models in clinical applications."
04/01/2004 - "Forty percent (28/70 cases) of the follicular thyroid carcinoma with lung metastases had history of thyroid surgery in this study. "
05/01/2000 - "In this study, we present a 58-year-old women with follicular thyroid carcinoma with vertebra and skull metastases. "
07/01/2006 - "The aim of study was evaluation of p53 and sFasL blood concentration in patients with benign follicular adenoma and follicular thyroid cancer. "
04/01/2015 - "The PAX8-PPARγ rearrangement was detected in 5 out of 15 follicular thyroid carcinoma cases (33.3%) and in 1 out of 15 follicular adenoma cases (6.6%). "
10/11/2012 - "The differential diagnostic of follicular thyroid adenomas and follicular thyroid carcinoma is a notorious challenge for pathologists. "
06/01/2012 - "In this paper, we investigate whether oxidative DNA damage and DNA repair differ in follicular adenoma (FA) and follicular thyroid carcinoma (FTC). "
12/01/2011 - "We investigated the following in hypofunctional follicular adenoma (FA) and follicular thyroid cancer (FTC): i) the mutation rate of frequently activated oncogenes, ii) the activation of DNA damage response checkpoints, and iii) the differential proteomic pattern between FA and FTC. "
05/01/2015 - "Of the 15 patients with RAS 61(+) -indeterminate nodules who underwent thyroid surgery, 14 (93·3%) were diagnosed as malignant, including 13 follicular variant of papillary thyroid carcinomas (FVPTC), and one follicular thyroid carcinoma (FTC). "
09/01/2013 - "Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?"
03/01/2013 - "This represents a rare presentation of a follicular thyroid carcinoma with initial recognition of a large, dedifferentiated metastatic lesion from a small primary carcinoma. "
01/01/2013 - "Differentiated thyroid carcinomas (DTCs) represent more than 90% of all thyroid carcinomas and comprise the papillary and follicular thyroid carcinoma subtypes. "
12/01/2012 - "Other carcinomas can metastasize to this area, but very few cases of follicular thyroid carcinoma metastasizing to the nasopharynx have been reported. "
|1.||papillary Thyroid cancer
|2.||Iodide Peroxidase (Deiodinase)
|4.||Factor IX (PTC)
|6.||anaplastic Thyroid cancer
|8.||Proteins (Proteins, Gene)
|9.||DNA (Deoxyribonucleic Acid)
|10.||Tretinoin (Retinoic Acid)
|3.||Lymph Node Excision (Lymph Node Dissection)
|4.||Neck Dissection (Radical Neck Dissection)
|5.||Hormone Replacement Therapy (Therapy, Hormone Replacement)